GALVANI, LINDA
GALVANI, LINDA
Borsisti
A new classification of upper gastrointestinal toxicity induced by immunotherapy: from endoscopic and pathological insights to clinical management
2024 Casadio, C.; Galvani, L.; De Giglio, A.; Casadei, C.; Tardio, M.L.; Melotti, B.; Sperandi, F.; Gelsomino, F.; Comito, F.
Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
2024 Compagno, Samuele; Casadio, Chiara; Galvani, Linda; Rosellini, Matteo; Marchetti, Andrea; Tassinari, Elisa; Piazza, Pietro; Mottaran, Angelo; Santoni, Matteo; Schiavina, Riccardo; Massari, Francesco; Mollica, Veronica
Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue
2023 Brandi G.; Deiana C.; Galvani L.; Palloni A.; Ricci A.D.; Rizzo A.; Tavolari S.
Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review
2023 Arianna Zappi; irene persano; Linda Galvani; Elena Parlagreco; Elisa Andrini; Davide Campana; Maria Pia Brizzi; Giuseppe Lamberti; ANNA LA SALVIA
Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review
2023 Nigro M.C.; Marchese P.V.; Deiana C.; Casadio C.; Galvani L.; Di Federico A.; De Giglio A.
Non-small-cell lung cancer: how to manage RET-positive disease
2022 Andrini E.; Mosca M.; Galvani L.; Sperandi F.; Ricciuti B.; Metro G.; Lamberti G.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A new classification of upper gastrointestinal toxicity induced by immunotherapy: from endoscopic and pathological insights to clinical management | Casadio, C.; Galvani, L.; De Giglio, A.; Casadei, C.; Tardio, M.L.; Melotti, B.; Sperandi, F.; Ge...lsomino, F.; Comito, F. | 2024-01-01 | ESMO GASTROINTESTINAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives | Compagno, Samuele; Casadio, Chiara; Galvani, Linda; Rosellini, Matteo; Marchetti, Andrea; Tassina...ri, Elisa; Piazza, Pietro; Mottaran, Angelo; Santoni, Matteo; Schiavina, Riccardo; Massari, Francesco; Mollica, Veronica | 2024-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | JCM 2024 [Novel Immuno RCC].pdf |
| Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue | Brandi G.; Deiana C.; Galvani L.; Palloni A.; Ricci A.D.; Rizzo A.; Tavolari S. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma.pdf |
| Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review | Arianna Zappi; irene persano; Linda Galvani; Elena Parlagreco; Elisa Andrini; Davide Campana; Mar...ia Pia Brizzi; Giuseppe Lamberti; ANNA LA SALVIA | 2023-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-12-00717.pdf |
| Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review | Nigro M.C.; Marchese P.V.; Deiana C.; Casadio C.; Galvani L.; Di Federico A.; De Giglio A. | 2023-01-01 | LUNG CANCER: TARGETS AND THERAPY | - | 1.01 Articolo in rivista | - |
| Non-small-cell lung cancer: how to manage RET-positive disease | Andrini E.; Mosca M.; Galvani L.; Sperandi F.; Ricciuti B.; Metro G.; Lamberti G. | 2022-01-01 | DRUGS IN CONTEXT | - | 1.01 Articolo in rivista | - |